Skip to main content
. 2019 Jun 3;13(9):761–771. doi: 10.2217/bmm-2018-0441

Table 2.  . Immunostaining scores and correlation of p16 and p53 in ADCs and SQCCs.

Markers IHC score Positive rate
  0 1 2 3  
p16          
ADC (n = 75) 37 (49.3%) 23 (30.7%) 12 (16.0%) 3 (4.0%) 50.7%
SQCC (n = 88) 57 (64.8%) 11 (12.5%) 8 (9.1%) 12 (13.6%) 35.2%
p53          
ADC (n = 75) 32 (42.7%) 20 (26.7%) 9 (12.0%) 14 (18.6%) 57.3%
SQCC (n = 88) 32 (36.4%) 10 (11.4%) 24 (27.2%) 22 (25.0%) 63.6%

ADC: Adenocarcinoma; IHC: Immunohistochemistry; SQCC: Squamous cell carcinoma.